Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $71.7 million.

  • Pediatrix Medical's Income from Continuing Operations rose 26884.93% to $71.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.2 million, marking a year-over-year increase of 16389.36%. This contributed to the annual value of -$99.1 million for FY2024, which is 6399.98% down from last year.
  • Latest data reveals that Pediatrix Medical reported Income from Continuing Operations of $71.7 million as of Q3 2025, which was up 26884.93% from $39.3 million recorded in Q2 2025.
  • Over the past 5 years, Pediatrix Medical's Income from Continuing Operations peaked at $71.7 million during Q3 2025, and registered a low of -$153.0 million during Q2 2024.
  • Moreover, its 5-year median value for Income from Continuing Operations was $23.6 million (2022), whereas its average is $7.5 million.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first skyrocketed by 130060.33% in 2021, then tumbled by 64106.85% in 2024.
  • Pediatrix Medical's Income from Continuing Operations (Quarter) stood at $40.3 million in 2021, then tumbled by 41.38% to $23.6 million in 2022, then plummeted by 626.46% to -$124.3 million in 2023, then soared by 124.52% to $30.5 million in 2024, then surged by 135.26% to $71.7 million in 2025.
  • Its Income from Continuing Operations stands at $71.7 million for Q3 2025, versus $39.3 million for Q2 2025 and $20.7 million for Q1 2025.